Medical device cybersecurity duties compared: manufacturers and hospitals
| Rule or guidance | Party | Duty | Citation and status |
|---|---|---|---|
| FD&C Act section 524B, Ensuring cybersecurity of devices1 | PartyA person who submits a premarket application or submission for a cyber device: a device that includes software validated, installed or authorized by the sponsor, can connect to the internet, and has characteristics that could be vulnerable to cybersecurity threats1 | DutyRequired: submit a plan to monitor, identify and address postmarket vulnerabilities and exploits in a reasonable time, including coordinated vulnerability disclosure; maintain processes giving reasonable assurance the device is cybersecure; make updates and patches available on a reasonably justified regular cycle for known unacceptable vulnerabilities, and as soon as possible out of cycle for critical ones; provide a software bill of materials covering commercial, open-source and off-the-shelf components1 | Citation and status21 U.S.C. 360n-2, added by Pub. L. 117-328 on December 29, 2022. FDA may exempt devices or categories by notice in the Federal Register1 |
| FDA FAQ on section 524B timing4 | PartyManufacturers of cyber devices4 | DutySection 524B took effect on March 29, 2023. Its requirements do not apply to applications or submissions made to FDA before that date4 | Citation and statusFDA, Cybersecurity Resources for Medical Device Manufacturers: Guidance, Resources, and FAQs (page content current as of 11/10/2026)4 |
| FDA premarket cybersecurity guidance2 | PartyDevice manufacturers, or another person submitting the application; covers devices with cybersecurity considerations, including devices that need no premarket submission. Section VII covers cyber devices under section 524B (510(k), PMA, PDP, De Novo and HDE submissions)2 | DutyNonbinding recommendations: a secure product development framework, threat modeling and security risk management; cybersecurity testing including penetration testing, with reports stating tester independence and expertise, scope, duration, methods and results; an SBOM in submissions and machine-readable SBOM information for users; security information in labeling2 | Citation and statusFinal guidance issued February 3, 2026 (docket FDA-2021-D-1158); supersedes the version issued June 27, 20252 |
| FDA postmarket cybersecurity guidance3 | PartyManufacturers of marketed and distributed medical devices3 | DutyNonbinding recommendations: remediate uncontrolled risks as quickly as possible. FDA does not intend to enforce 21 CFR part 806 reporting for a vulnerability with uncontrolled risk when there are no known serious adverse events or deaths, the manufacturer tells customers within 30 days, fixes the vulnerability and distributes the fix within 60 days, and actively participates in an ISAO3 | Citation and statusFinal guidance issued December 28, 2016 (docket FDA-2015-D-5105)3 |
| FDA FAQ on patching by health care delivery organizations4 | PartyHealth care delivery organizations4 | DutyFDA recognizes they may need to patch or update devices or supporting infrastructure, and recommends working closely with device manufacturers to communicate changes that are requested or necessary4 | Citation and statusFDA, Cybersecurity Resources for Medical Device Manufacturers: Guidance, Resources, and FAQs; guidance, not a rule4 |
| HIPAA Security Rule, security management process5 | PartyCovered entities and business associates, for the ePHI they hold5 | DutyRequired: an accurate and thorough assessment of potential risks and vulnerabilities to the confidentiality, integrity and availability of ePHI (risk analysis), and security measures that reduce risks and vulnerabilities to a reasonable and appropriate level (risk management)5 | Citation and status45 CFR 164.308(a)(1)(ii)(A) and (B)5 |
| HIPAA Security Rule, device and media controls6 | PartyCovered entities and business associates6 | DutyPolicies and procedures for the receipt and removal of hardware and electronic media that contain ePHI, and their movement within the facility. Disposal and media re-use procedures are required; a record of movements is addressable6 | Citation and status45 CFR 164.310(d)6 |
License: CC BY 4.0. Underlying government texts are public domain or under their own terms. Attribute "Moraph Insights" with a link to the page.
Method
We read section 524B in the 2024 edition of the U.S. Code on govinfo, FDA's current premarket cybersecurity guidance (the February 3, 2026 PDF), the 2016 postmarket guidance PDF, FDA's cybersecurity resources and FAQ page for manufacturers, and 45 CFR 164.308 and 164.310 in the eCFR. Each cell was checked on 2026-11-14. Statutory and regulatory duties are marked as requirements; FDA guidance and FAQ answers are recommendations, as the documents themselves say. The HIPAA rows cite the rule's own wording, which covers ePHI generally and does not single out medical devices in the sections cited. This table explains the rules; it is not legal advice. Time-sensitive cells were re-checked against their sources on 2026-11-14.
Omitted
What was left out, and why.
- A row left out: No joint HHS and CISA medical device resource was confirmed on an official page on 2026-11-13; HHS pages block automated access and CISA's healthcare sector page did not list one.
- A row left out: Left out to keep this table to rules in force and current FDA guidance; the proposed HIPAA Security Rule update is compared in hipaa-security-rule-current-vs-proposed.
Notes
- FDA guidance documents state that they contain nonbinding recommendations; the duties in section 524B and the HIPAA Security Rule are binding.
Sources
- U.S. Government Publishing Office (U.S. Code). 21 U.S.C. 360n-2, Ensuring cybersecurity of devices (FD&C Act section 524B), U.S. Code 2024 edition. Checked .
- U.S. Food and Drug Administration. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions, final guidance (February 3, 2026). Checked .
- U.S. Food and Drug Administration. Postmarket Management of Cybersecurity in Medical Devices, final guidance (December 2016). Checked .
- U.S. Food and Drug Administration. Cybersecurity Resources for Medical Device Manufacturers: Guidance, Resources, and FAQs. Checked .
- U.S. Department of Health and Human Services. 45 CFR 164.308, Administrative safeguards (HIPAA Security Rule). Checked .
- U.S. Department of Health and Human Services. 45 CFR 164.310, Physical safeguards (HIPAA Security Rule). Checked .
How we source and check every fact: Editorial standards · Corrections
Last reviewed .
Spotted an error? Tell us and we will check it and correct the table where needed.